Embody, a Norfolk, Virginia based medical device company developing collagen-based products for the treatment of tendon and ligament injuries, raised a convertible debt funding round of undisclosed amount.
The round was led by The 757 Angels round, with participation from CIT GAP Funds and individual investors.
The company intends to use the funds to advance the treatment of tendon and ligament injuries for warfighters and sports medicine patients.
Led by Jeff Conroy, CEO, Embody aims to improve the standard of care for soft tissue injuries by providing implantable medical devices that promote faster healing and restore pre-injury performance.
The company has been funded with $12m from the Defense Advanced Research Projects Agency (DARPA) based on the need to advance the treatment standards for warfighters and veterans.
FinSMEs
29/08/2018